Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 114
- Uncategorized
Canadian Government Could Face Class Action Lawsuit Over Cannabis Legalisation
The Canadian Federal government’s failure to facilitate research into the potential health issues associated with cannabis consumption.
- Markets & Stocks
MGC Pharma Announces New A$2.7m Share Purchase Plan, Chill Brands Revenues Drop 87%, & Hellenic Receives EU Grant
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals released a flurry of updates over the last week, announcing plans to launch a A$2.7m share purchase plan for its Australian investors, just weeks after conditionally raising a further £700,000.
- Uncategorized
New CURE Act Would Prevent Cannabis Use Being Grounds For Dismissal for Federal Employees
New legislation introduced in the US last week seeks to ease federal restrictions on employees who are past or current cannabis users.
- Medical
UK Medical Cannabis Industry Gathers Momentum Amid Numerous Research Milestones
The UK’s National Health Service (NHS) Research Ethics Committee this week approved the full-scale rollout of a new clinical trial into medical cannabis and non-cancer chronic pain.
- Uncategorized
New York Officials Close Another 7 Unlicensed Cannabis Stores
Another seven unlicensed cannabis dispensaries were shut down in New York yesterday as state officials continue their crackdown.
- Uncategorized
Tilray Shares Jump 15% as Losses Narrow and Sales Beat Estimates
Tilray has reported narrowing losses during its fourth quarter while sales came in well above analyst estimates, leading to a bump in stock price.
- Markets & Stocks
Cantourage Expects ‘Double Digit’ Sales Increase This Year, Apollon Signs New Licence Agreement, & More from MGC Pharma
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German-listed cannabis distributor Cantourage informed investors this week that it expects to see ‘double digit’ sales growth and ‘a break-even result at EBITDA level’ in 2023.
- Uncategorized
Barbados’ Positions Itself To Launch Thriving Medical Cannabis Industry
Barbados’ cannabis authority has today announced a new partnership with cannabis technology company GrowerIQ, which will see it manage the tracking and reporting of all production on the island.
- Medical
Barbados’ Positions Itself To Launch Thriving Medical Cannabis Industry
Barbados’ cannabis authority has today announced a new partnership with cannabis technology company GrowerIQ, which will see it manage the tracking and reporting of all production on the island.
- Uncategorized
New York’s Empire Cannabis Club to Take Regulators to Court After Recent Raids
Empire Cannabis Club, one of New York’s largest and highest profile unlicensed cannabis businesses, has pledged to take regulators to court to prove its legality.
- Cultivation
Albania Officially Green Lights Medical and Industrial Cannabis Cultivation
Albania has become the latest European country to officially legalise the ‘cultivation and processing of the cannabis plant and the production of its by-products for medical and industrial purposes’.
- Uncategorized
Cookies Accused of ‘Burning Through Cash and Running Out of Money’ by Investor Group
California cannabis giant Cookies is now being targeted in a third ongoing legal case, with plaintiffs accusing the company of mismanaging tens of millions of dollars.









